Latest news on first-ever Lag-3 OK; Aduhelm support, criticism both crescendo; Pharma gets firm about Russia; Setbacks mar top R&D prospects; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
We are keeping in close touch with our colleagues in Ukraine, who are always in our thoughts. For those of you who have friends or family affected by this war, we share your wish that they will find peace and reunite with loved ones soon.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.